NCT06732401 2026-03-18
Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 3 Suspended
Clinical Trials
8 trialsNCT06159790 2026-03-04
A Study to Compare Efficacy, Safety, and Immunogenicity of GME751 and EU-authorized Keytruda in Adult Participants With Untreated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)
Sandoz
Phase 3 Suspended
NCT06671912 2026-03-04
LoTam
Alliance for Clinical Trials in Oncology
Phase 3 Suspended
NCT03150693 2026-03-02
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Alliance for Clinical Trials in Oncology
Phase 3 Suspended
NCT05378763 2026-02-18
PINNACLE
Spectrum Pharmaceuticals, Inc
Phase 3 Suspended
NCT05351294 2026-01-07
Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet
Rutgers, The State University of New Jersey
Phase 3 Suspended
NCT06940570 2025-10-23
MATCH
University of Texas Southwestern Medical Center
Phase 3 Suspended
NCT04973930 2025-05-13
IPT
New York State Psychiatric Institute
Phase 3 Suspended